Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.99 -0.19 (-1.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Asset Writedowns and Impairment (2024 - 2026)

Updated

Zevra Therapeutics (ZVRA) posted Asset Writedowns and Impairment of $500,000 for Q1 2026.

Analysis

Zevra Therapeutics (ZVRA) Asset Writedowns and Impairment (2024 - 2026) Analysis & Trends

For FY2025, Zevra Therapeutics' Asset Writedowns and Impairment came in at $58.71 million, up 921.8% from FY2024.

  • In prior years, Zevra Therapeutics' Asset Writedowns and Impairment was $5.75 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Zevra Therapeutics 592.83 Mn -219.88 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Jun 30, 2025 58.71 Mn
Dec 31, 2024 502,000.00
Sep 30, 2024 2.00 Mn
Jun 30, 2024 3.20 Mn
API Access

Zevra Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ZVRA&period=max&api_key=YOUR_API_KEY